Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Pelossof

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Genes, Chromosomes & Cancer|March 26, 2016
Reply to Cristóbal and Co-authors' comment, deregulation of miR-92a in locally advanced rectal cancerRaphael Pelossof, Oliver Chow, Julio Garcia-Aguilar
Genome Research|September 4, 2014
Linking signaling pathways to transcriptional programs in breast cancerHatice U Osmanbeyoglu, Raphael Pelossof, Jacqueline F Bromberg, et al.
Nature Communications|May 18, 2017
An integrated model for detecting significant chromatin interactions from high-resolution Hi-C dataMark Carty, Lee Zamparo, Merve Sahin, et al.
Nature Biotechnology|November 17, 2015
Affinity regression predicts the recognition code of nucleic acid-binding proteinsRaphael Pelossof, Irtisha Singh, Julie L Yang, et al.
Journal of Biomolecular Screening|August 29, 2014
Impact of RNA-guided technologies for target identification and deconvolutionMyles Fennell, Qing Xiang, Alexia Hwang, et al.
Briefings in Bioinformatics|April 7, 2022
Privacy preserving validation for multiomic prediction modelsTalal Ahmed, Mark A Carty, Stephane Wenric, et al.
Genes, Chromosomes & Cancer|February 12, 2016
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerRaphael Pelossof, Oliver S Chow, Lauren Fairchild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?Irit Ben-Aharon, Moshe Elkabets, Raphael Pelossof, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Genes, Chromosomes & Cancer|March 26, 2016
Reply to Cristóbal and Co-authors' comment, deregulation of miR-92a in locally advanced rectal cancerRaphael Pelossof, Oliver Chow, Julio Garcia-Aguilar
Genome Research|September 4, 2014
Linking signaling pathways to transcriptional programs in breast cancerHatice U Osmanbeyoglu, Raphael Pelossof, Jacqueline F Bromberg, et al.
Nature Communications|May 18, 2017
An integrated model for detecting significant chromatin interactions from high-resolution Hi-C dataMark Carty, Lee Zamparo, Merve Sahin, et al.
Nature Biotechnology|November 17, 2015
Affinity regression predicts the recognition code of nucleic acid-binding proteinsRaphael Pelossof, Irtisha Singh, Julie L Yang, et al.
Journal of Biomolecular Screening|August 29, 2014
Impact of RNA-guided technologies for target identification and deconvolutionMyles Fennell, Qing Xiang, Alexia Hwang, et al.
Briefings in Bioinformatics|April 7, 2022
Privacy preserving validation for multiomic prediction modelsTalal Ahmed, Mark A Carty, Stephane Wenric, et al.
Genes, Chromosomes & Cancer|February 12, 2016
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerRaphael Pelossof, Oliver S Chow, Lauren Fairchild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?Irit Ben-Aharon, Moshe Elkabets, Raphael Pelossof, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
Pageof 2